119 related articles for article (PubMed ID: 15717631)
21. Anticardiolipin antibodies in children on chronic haemodialysis.
Sallam S; Wafa E; el-Gayar A; Sobh M; Salama O
Nephrol Dial Transplant; 1994; 9(9):1292-4. PubMed ID: 7816292
[TBL] [Abstract][Full Text] [Related]
22. Far-infrared therapy: a novel treatment to improve access blood flow and unassisted patency of arteriovenous fistula in hemodialysis patients.
Lin CC; Chang CF; Lai MY; Chen TW; Lee PC; Yang WC
J Am Soc Nephrol; 2007 Mar; 18(3):985-92. PubMed ID: 17267744
[TBL] [Abstract][Full Text] [Related]
23. Elevated anticardiolipin antibodies in schizophrenic patients before and during neuroleptic medication.
Halacheva K; Dimova S; Tolev T; Dimov D; Nikolova M
Psychiatry Res; 2009 Aug; 169(1):51-5. PubMed ID: 19596154
[TBL] [Abstract][Full Text] [Related]
24. Platelet adhesion testing may predict early hemodialysis arteriovenous graft and fistula failure in end-stage renal disease patients.
ElChoufani SE; Bolin P; Waien S; Christiano CR; Holbert D; Bode AP
Clin Appl Thromb Hemost; 2008 Oct; 14(4):399-409. PubMed ID: 18160614
[TBL] [Abstract][Full Text] [Related]
25. High titer of anti-phosphatidylserine-prothrombin complex antibodies in patients with cutaneous polyarteritis nodosa.
Kawakami T; Yamazaki M; Mizoguchi M; Soma Y
Arthritis Rheum; 2007 Dec; 57(8):1507-13. PubMed ID: 18050170
[TBL] [Abstract][Full Text] [Related]
26. Association of serum lipid profile and arteriovenous fistula thrombosis in maintenance hemodialysis patients.
Kirkpantur A; Arici M; Altun B; Yilmaz MI; Cil B; Aki T; Bakkaloglu M; Turgan C
Blood Purif; 2008; 26(4):322-32. PubMed ID: 18487877
[TBL] [Abstract][Full Text] [Related]
27. Risk of vascular access thrombosis in patients with systemic lupus erythematosus on hemodialysis.
Shafi ST; Gupta M
J Vasc Access; 2007; 8(2):103-8. PubMed ID: 17534796
[TBL] [Abstract][Full Text] [Related]
28. IgG and IgM anticardiolipin antibodies following treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis.
Visvanathan S; Wagner C; Smolen J; St Clair EW; Hegedus R; Baker D; Keenan G
Arthritis Rheum; 2006 Sep; 54(9):2840-4. PubMed ID: 16948115
[TBL] [Abstract][Full Text] [Related]
29. Effects of smoking and blood eosinophil count on the development of arteriovenous fistulae thrombosis in hemodialysis patients.
Ozdemir FN; Akcay A; Bilgic A; Akgul A; Arat Z; Haberal M
Transplant Proc; 2005 Sep; 37(7):2918-21. PubMed ID: 16213261
[TBL] [Abstract][Full Text] [Related]
30. The pathogenesis of pulmonary hypertension in haemodialysis patients via arterio-venous access.
Nakhoul F; Yigla M; Gilman R; Reisner SA; Abassi Z
Nephrol Dial Transplant; 2005 Aug; 20(8):1686-92. PubMed ID: 15840664
[TBL] [Abstract][Full Text] [Related]
31. Elevated serum IgA anticardiolipin antibody levels in adult Henoch-Schönlein purpura.
Kawakami T; Watabe H; Mizoguchi M; Soma Y
Br J Dermatol; 2006 Nov; 155(5):983-7. PubMed ID: 17034529
[TBL] [Abstract][Full Text] [Related]
32. Effect of 1-year oral alpha-tocopherol administration on anticardiolipin antibodies in hemodialysis patients.
Antoniadi G; Eleftheriadis T; Liakopoulos V; Kakasi E; Vayonas G; Kortsaris A; Vargemezis V
Ren Fail; 2005; 27(2):193-8. PubMed ID: 15807185
[TBL] [Abstract][Full Text] [Related]
33. Association of anticardiolipin antibodies with vascular access occlusion in hemodialysis patients: cause or effect?
Haviv YS
Nephron; 2000 Dec; 86(4):447-54. PubMed ID: 11124593
[TBL] [Abstract][Full Text] [Related]
34. Predicting hemodialysis access failure with the measurement of dialysis access recirculation.
Salimi J; Razeghi E; Karjalian H; Meysamie A; Dahhaz M; Dadmehr M
Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):781-4. PubMed ID: 18711295
[TBL] [Abstract][Full Text] [Related]
35. Anticardiolipin and antinuclear antibodies in the adult healthy Omani individuals.
Al Jabri AA; Al Buloshi MS
Saudi Med J; 2004 Mar; 25(3):313-7. PubMed ID: 15048168
[TBL] [Abstract][Full Text] [Related]
36. Haemodialysis vascular access problems in Canada: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS II).
Mendelssohn DC; Ethier J; Elder SJ; Saran R; Port FK; Pisoni RL
Nephrol Dial Transplant; 2006 Mar; 21(3):721-8. PubMed ID: 16311264
[TBL] [Abstract][Full Text] [Related]
37. High prevalence of anticardiolipin antibodies in patients with asymptomatic hepatitis C virus infection associated acute ischemic stroke.
Cojocaru IM; Cojocaru M; Iacob SA
Rom J Intern Med; 2005; 43(1-2):89-95. PubMed ID: 16739869
[TBL] [Abstract][Full Text] [Related]
38. High titer of anticardiolipin antibody is associated with first-ever ischemic stroke in Taiwan.
Lien LM; Chen WH; Chiu HC; Pan WH; Chen JR; Bai CH
Cerebrovasc Dis; 2006; 22(4):225-30. PubMed ID: 16788294
[TBL] [Abstract][Full Text] [Related]
39. Anticardiolipin antibodies, recurrent stroke and vascular events: a prospective study on 210 patients.
Tănăsescu R; Ticmeanu M; Nicolau A; Uscătescu V; Cojocaru M; Grecu V; Serbănescu A
Rom J Intern Med; 2005; 43(1-2):79-88. PubMed ID: 16739868
[TBL] [Abstract][Full Text] [Related]
40. Thrombophilia and the risk for hemodialysis vascular access thrombosis.
Knoll GA; Wells PS; Young D; Perkins SL; Pilkey RM; Clinch JJ; Rodger MA
J Am Soc Nephrol; 2005 Apr; 16(4):1108-14. PubMed ID: 15728780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
